These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10328843)

  • 1. Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs.
    Belloli C; Crescenzo G; Carli S; Zaghini A; Mengozzi G; Bertini S; Ormas P
    Vet J; 1999 May; 157(3):315-21. PubMed ID: 10328843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis.
    Belloli C; Ceci L; Carli S; Tassi P; Montesissa C; De Natale G; Marcotrigiano G; Ormas P
    Res Vet Sci; 1995 Mar; 58(2):123-7. PubMed ID: 7761689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
    Valladares JE; Alberola J; Esteban M; Arboix M
    Vet Rec; 1996 Feb; 138(8):181-3. PubMed ID: 8677619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate.
    Friedrich K; Vieira FA; Porrozzi R; Marchevsky RS; Miekeley N; Grimaldi G; Paumgartten FJ
    J Toxicol Environ Health A; 2012; 75(2):63-75. PubMed ID: 22129235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
    Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M
    Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate.
    Schettini DA; Costa Val AP; Souza LF; Demicheli C; Rocha OG; Melo MN; Michalick MS; Frézard F
    Braz J Med Biol Res; 2005 Dec; 38(12):1879-83. PubMed ID: 16302103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
    Chulay JD; Fleckenstein L; Smith DH
    Trans R Soc Trop Med Hyg; 1988; 82(1):69-72. PubMed ID: 2845611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.
    Athanasiou LV; Saridomichelakis MN; Kontos VI; Spanakos G; Rallis TS
    Vet Parasitol; 2013 Feb; 192(1-3):91-7. PubMed ID: 23140991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
    Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
    Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog.
    Chapman WL; Hanson WL; Alving CR; Hendricks LD
    Am J Vet Res; 1984 May; 45(5):1028-30. PubMed ID: 6732008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of liposome-encapsulated antimony in dogs.
    Schettini DA; Costa Val AP; Souza LF; Demicheli C; Rocha OG; Melo MN; Michalick MS; Frézard F
    Braz J Med Biol Res; 2003 Feb; 36(2):269-72. PubMed ID: 12563530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
    Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
    Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tolerability of aminosidine after repeated administrations using an optimal dose regimen in healthy dogs and in dogs with leishmaniosis.
    Athanasiou LV; Batzias GC; Saridomichelakis MN; Delis G; Soubasis N; Kontos VI; Rallis TS
    Vet Parasitol; 2014 Sep; 205(1-2):365-70. PubMed ID: 24998095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs.
    Valladares JE; Freixas J; Alberola J; Franquelo C; Cristofol C; Arboix M
    Am J Trop Med Hyg; 1997 Oct; 57(4):403-6. PubMed ID: 9347953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis.
    Azevedo EG; Ribeiro RR; da Silva SM; Ferreira CS; de Souza LE; Ferreira AA; de Oliveira E Castro RA; Demicheli C; Rezende SA; Frézard F
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1551-60. PubMed ID: 24962630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
    Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
    Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fluconazole on the pharmacokinetics and pharmacodynamics of antimony in cutaneous leishmaniasis-infected hamsters.
    Alnaim L; Abou Alsoud N; Zaghloul I; Al-Jaser M
    Int J Antimicrob Agents; 2007 Jun; 29(6):728-32. PubMed ID: 17369029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis.
    Miekeley N; Mortari SR; Schubach AO
    Anal Bioanal Chem; 2002 Feb; 372(3):495-502. PubMed ID: 11939540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
    Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.